Enterprise ABM Strategy (Healthcare)
Why Account-Based Marketing Fails Before It Starts
Account-based marketing is one of those strategies that looks straightforward in a conference presentation and turns out to be deceptively hard to execute well. Most organizations that invest in ABM get some version of it right. Very few get all of it right at the same time. And the gap between "some of it" and "all of it" is where most of the results live.
The Setup
The client was a healthcare enterprise operating in a complex, relationship-driven market. Their sales cycles were long. Their buyers were senior. The purchasing decisions involved multiple stakeholders across clinical, administrative, and financial functions. And the volume of accounts worth targeting was finite — which meant every account mattered, and wasted spend on the wrong message to the wrong person at the wrong time was genuinely costly.
Standard demand generation wasn't built for this problem. What they needed was an ABM program designed for the specific complexity of enterprise healthcare sales.
Where ABM Programs Break Down
Before I get into what we built, it's worth naming the failure modes I see most often — because they're predictable, and recognizing them early is the first step to avoiding them.
The first failure mode is a target account list that isn't actually strategic. Organizations pull a list of companies that look like their customers and call it an ICP. They're not the same thing. A real ICP is built on firmographic data, technographic signals, intent data, and sales intelligence — not just "companies in our space with the right headcount."
The second failure mode is single-threaded account engagement. ABM is, by definition, about engaging buying committees — not just the person whose title matches your target persona. If your campaigns are only reaching one stakeholder per account, you're running demand gen with better targeting, not ABM.
The third failure mode is the absence of a measurement framework that sales and marketing actually agree on. ABM is a team sport. If marketing is measuring account engagement and sales is measuring pipeline, and nobody is measuring the relationship between the two, the program will eventually collapse under the weight of misaligned expectations.
What We Built
For this client, we started with account selection — building a tiered target account list based on a real ICP, prioritized by potential deal value, strategic fit, and signals of active buying intent.
From there, we mapped the buying committees within each priority account. Not just titles — but roles, concerns, and influence on the decision. We identified the clinical champion, the administrative gatekeeper, the financial approver, and the procurement stakeholder. Each required a different message.
We built a messaging architecture that addressed each stakeholder's specific priorities, and developed content and channel strategies to reach them on the platforms and in the formats where they were most likely to engage.
Finally, we built the measurement framework — shared between marketing and sales — that defined what account progression looked like, how engagement was tracked, and what signals indicated a transition from marketing engagement to sales readiness.
The Strategic Takeaway
ABM works when the foundational decisions — account selection, buying committee mapping, stakeholder messaging, and shared measurement — are made before a single ad is run or a single email is sent.
The tactical layer of ABM is not complicated. The strategic layer is where most programs fail. Get that right first, and the results follow.
